Chemohormonal therapy for malignant melanomas of the nasal and paranasal mucosa

Rhinology

Volumn 35, Issue 1, 1997, Pages 19-21

  Seo, Wataru ^a   Ogasawara, Hiroshi ^a   Sakagami, Masafumi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Chemohormonal therapy; Estrogen receptor; Malignant melanoma; Tamoxifen

Indexed keywords

CISPLATIN; DACARBAZINE; RANIMUSTINE; TAMOXIFEN; TAMOXIFEN CITRATE; VINBLASTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; EPISTASIS; HISTOPATHOLOGY; HUMAN; MALE; MELANOMA; NOSE SURGERY; PARANASAL SINUS CARCINOMA; TUMOR BIOPSY;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ESTROGEN ANTAGONISTS; FATAL OUTCOME; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NASAL CAVITY; NASAL MUCOSA; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; TAMOXIFEN;

EID: 0030907462     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Creagan ET, Ingl JN, Green SJ (1980) Phase-II study of tamoxifen in patients with disseminated melanoma. Cancer Treatm Rep 64: 166-201.
2. Del Prete SA, Maurer LH, O'Donnell (1984) Combination chemotherapy with cisplatin, carmustine, dacarbazine and tamoxifen in metastatic melanoma. Cancer Treatm Rev 68: 1403-1405.
3. Fisher RI, Nelfeld JP, Lippmann ME (1976) Estrogen receptors in human malignant melanoma Lancet 2: 337-338.
4. Fisher RI, Young RC, Lippmann ME (1981) Diethylstilbestrol therapy of surgically non-resectable malignant melanoma. Proc Amer Assoc Cancer Res/ASCO 19: 339.
5. Hofmann J, Doppler W, Jakob A (1988) Enhancement of the anti-proliferative action of CDDP and nitrogen mustard by inhibitors of protein kinase C. Int J Cancer 42: 382-388.
6. Lee SP, Shimizu KT, Tran LM (1994) Mucosal melanoma of the head and neck. The impact of local control on survival. Laryngoscope 104: 121-126.
7. Lund VJ (1993) Malignant melanoma of the nasal cavity and paranasal sinuses. ENT Journal 72: 285-290.
8. Mann SP, Andrew DA, Howell, SB (1989) Modulation of cisplatin accumulation by forskolin in human ovarian carcinoma cells. Proc Amer Assoc Cancer Res 30: 1851.
9. Masiel A, Buttrick P, Bitran J (1981) Tamoxifen in the treatment of malignant melanoma. Cancer Treatm Rep 65: 531-532
10. McClay EF, Nasarangelo MJ, Bread D (1992) Effective combination chemohormonal therapy for malignant melanoma. Int J Cancer 50: 553-556.
11. McClay EF, Albright KA, Jones, JA (1993a) Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma: A biologically important observation. Cancer 72: 1914-1918.
12. McClay EF, Christian R, Albright KA (1993b) Tamoxifen modulation of cisplatin cytotoxity in human malignancies. Int J Cancer 55: 1018-1022.
13. Mirimanoff RO, Wagenknecht L, Hunziker, L (1981) Long-term complete remission of malignant melanoma with tamoxifen. Lancet 1, 1368-1369.
14. Nesbit RA, Woods RL, Tatrersall MH (1979) tamoxifen in malignant melanoma. N Eng J Med 301: 1241.
15. Papac R, Luikhart S. Kirkwood J (1980) High dose tamoxifen in patients with advanced renal cell cancer and malignant melanoma. Proc Amer Assoc Cancer Res/ASCO 21: 34.